Chen-Ming Yu

Director, Sagent Pharmaceuticals, Inc.

Companies

TCGX Acquisition Corp.Chief executive officer Aug 4, 2026 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Recent filings

Jul 22, 2026Sold 162,500 shares at $21.25 of Surrozen, Inc./DE²
Jul 22, 2026Sold 162,500 shares at $21.25 of Surrozen, Inc./DE²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTCGX Acquisition Corp., Chief executive officer
2
SEC EDGARForm 4 filed Jul 24, 2026